The global generic oncology drugs market is experiencing steady growth as healthcare systems increasingly prioritize cost-effective cancer treatment solutions. The rising global burden of cancer, coupled with the need to reduce treatment costs, is significantly driving the adoption of generic alternatives. These drugs offer comparable efficacy to branded therapies at a much lower cost, making...